How AI Can Decrease Drug-related Health Equity Challenges - insideBIGDATA

Surveyor Health Corporation launched the SurveyorAI platform, a patented technology that drives efficiency and affordability for population medication management using drug knowledge from FDB (First Databank). The company also released the results of a Stanford-guided two-year study and peer reviewed research in the Journal of Managed Care & Specialty Pharmacy. The study validates the platform's ability to enhance remote medication management while lowering costs, reducing utilization, and improving health. The results of the study are based on a pilot conducted with IEHP, Inland Empire Health Plan, one of the top 10 largest Medicaid health plans and the largest not-for-profit Medicare-Medicaid plan in the country. "Adverse drug reactions result in 275,689 deaths and cost more than $528 billion per year*," said Erick Von Schweber, co-founder of Surveyor Health Corporation.